Cardiometabolic Testing

1 in 3 American adults have some form of cardiovascular disease – and this “silent killer” remains the largest cause of death for both men and women. Cardiometabolic Testing by Confidia can find microscopic heart disease – which is reversible if treated. Our unique, multi-test approach identifies cardiovascular diseases years before they manifest, become problematic, and lead to heart attacks and stroke.

Symptoms & Conditions

Cardiovascular Disease Symptoms & Conditions

What makes Cardiovascular Disease (CVD) especially troublesome is that its first sign is often a fatal heart attack or stroke. While it primarily involves the heart and blood vessels, Cardiovascular Disease can also affect your brain, limbs, and other body systems.

Symptoms may be different for men and women. For instance, men are more likely to notice chest pain, while women may experience shortness of breath, nausea, or extreme fatigue. Symptoms and conditions of Confidia patients who received Cardiometabolic Blood Testing include:

If you’re wondering whether you might have hidden Cardiovascular Disease, schedule a True Health Evaluation™ today.

SCHEDULE APPOINTMENT

Inside The Science

Increased Risk of Heart Disease in Women

Women are at increased risk of heart disease as they age. Most don’t know that: 

• Women are 8 times more likely to die from a heart attack than from breast cancer. Although the number of deaths from breast cancer is stabilizing due to early detection and treatment, deaths from heart disease are increasing for women.
• After age 45, the same percentage of women and men have high blood pressure. After age 64, a higher percentage of women have high blood pressure than men.
• Each year, approximately 55,000 more women than men have strokes caused by plaque build-up. Plaque builds up in the carotid arteries more rapidly post-menopause.

Microscopic vs Macroscopic Cardiac Testing

Testing can find cardiac disease years before it manifests inside you – if that testing is done microscopically. Confidia Health Institute uses a unique, multi-test approach to assess and identify cardiovascular diseases at the microscopic level. Microscopic identification is vital because if nothing is done about cardiac disease within a 10-20 year period, the disease becomes macroscopic – which leads to heart attacks and strokes. CardioMetabolic Testing by Confidia can find microscopic heart disease – which is reversible if treated.

What Cardiac Testing Does Confidia Perform?

Confidia Health Institute analyzes the data from several cardiovascular tests to identify heart disease – and to inform a personalized treatment plan.

Confidia cardiac testing includes:

• Autonomic Nervous System (ANS) Testing

ANS Testing analyzes physiologic processes that are not under conscious control: blood pressure, heart rate, body temperature, metabolism, and more. These tests can determine your risk of heart disease and stroke, as well as a range of other health issues.

• Ankle-Brachial Peripheral Artery Disease (ABI PAD) Testing

ABI Testing checks how effectively your blood is flowing and whether you have blockages in the arteries of your arms and legs. If you have Peripheral Artery Disease detected with the ABI test, you’re more than likely to have a heart attack or stroke.

• Carotid Intima-Media Thickness (IMT) Testing

IMT Testing checks for early detection of heart disease. The test assesses the presence and severity of plaque in the carotid artery, as well as the vulnerability of the plaque to rupture and cause a heart attack or stroke.

How Much Does Cardiometabolic Testing Cost? 

The average cost through insurance is $750. These tests are vital in the prevention of heart attack and stroke — which is why Confidia is making it easier than ever to get access to advanced Cardiometabolic testing, without the expensive paywall. When performed through Confidia, all three tests come to $250.
 

Outcomes